Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk‐stratification and management

A Tefferi, T Barbui - American journal of hematology, 2015 - Wiley Online Library
Disease overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms, respectively characterized by erythrocytosis and …

[PDF][PDF] Guideline for investigation and management of adults and children presenting with a thrombocytosis.

CN Harrison, D Bareford, N Butt… - British journal of …, 2010 - thebloodproject.com
1Guy's and St Thomas' NHS Foundation Trust, London, 2Russells Hall Hospital, Dudley,
West Midlands, 3Arrowe Park Hospital Arrowe Park Road Upton Wirral, 4Wellcome Trust …

Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk‐stratification, and management

A Tefferi, T Barbui - American journal of hematology, 2017 - Wiley Online Library
Abstract Disease overview Polycythemia Vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms respectively characterized by erythrocytosis and …

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet

T Barbui, G Barosi, G Birgegard, F Cervantes… - Journal of clinical …, 2011 - ascopubs.org
We present a review of critical concepts and produce recommendations on the management
of Philadelphia-negative classical myeloproliferative neoplasms, including monitoring …

A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation …

F Passamonti, E Rumi, D Pietra, C Elena, E Boveri… - Leukemia, 2010 - nature.com
We studied the relationship between JAK2 (V617F) mutant allele burden and clinical
phenotype, disease progression and survival in patients with polycythemia vera (PV). The …

NCCN guidelines insights: myeloproliferative neoplasms, version 2.2018

RA Mesa, C Jamieson, R Bhatia, MW Deininger… - Journal of the National …, 2017 - jnccn.org
Myeloproliferative neoplasms (MPNs) are a group of heterogeneous disorders of the
hematopoietic system that include myelofibrosis (MF), polycythemia vera (PV), and essential …

Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management

A Tefferi - American journal of hematology, 2012 - Wiley Online Library
Disease overview: Polycythemia vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms primarily characterized by erythrocytosis and thrombocytosis …

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

F Passamonti, E Rumi, L Arcaini, E Boveri… - …, 2008 - haematologica.org
Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients
with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia …

Haematological cancers in pregnancy

B Brenner, I Avivi, M Lishner - The Lancet, 2012 - thelancet.com
Haematological cancer in pregnancy, although rare, poses a substantial risk to both mother
and fetus. Hodgkin's lymphoma is the most common, followed by non-Hodgkin lymphoma …

Polycythemia vera and essential thrombocythemia: 2013 update on diagnosis, risk‐stratification, and management

A Tefferi - American journal of hematology, 2013 - Wiley Online Library
Disease Overview Polycythemia Vera (PV) and essential thrombocythemia (ET) are
myeloproliferative neoplasms (MPN) primarily characterized by erythrocytosis and …